SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-061530
Filing Date
2023-03-06
Accepted
2023-03-06 16:59:23
Documents
5
Effectiveness Date
2023-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 d453401ds8.htm S-8 43302
2 EX-5.1 d453401dex51.htm EX-5.1 8253
3 EX-23.1 d453401dex231.htm EX-23.1 1649
4 EX-FILING FEES d453401dexfilingfees.htm EX-FILING FEES 20953
5 GRAPHIC g453401g0304031204514.jpg GRAPHIC 2534
  Complete submission text file 0001193125-23-061530.txt   78845
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270304 | Film No.: 23709695
SIC: 2834 Pharmaceutical Preparations